Opus Genetics, Inc. (IRD) — Financial Flexibility Index
Opus Genetics, Inc. (IRD) has a Financial Flexibility Index of -0.28x as of December 2025. Free cash flow of $-9.83 Million (operating CF $-9.83 Million minus capex $0.00) represents 0% of total liabilities ($34.90 Million). Check IRD financial resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Opus Genetics, Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Opus Genetics, Inc. across 7 annual periods. See IRD net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Opus Genetics, Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for Opus Genetics, Inc.. For the full company profile including market capitalisation, see market value of Opus Genetics, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.01x | $-35.25 Million | $-35.25 Million | $34.90 Million | ▼ -19.0% |
| 2024 | -0.85x | $-25.58 Million | $-25.58 Million | $30.14 Million | ▼ -208.5% |
| 2023 | -0.28x | $-1.11 Million | $-1.11 Million | $4.04 Million | ▼ -105.3% |
| 2022 | 5.20x | $14.31 Million | $14.31 Million | $2.75 Million | ▲ +203.5% |
| 2021 | -5.02x | $-19.37 Million | $-19.37 Million | $3.85 Million | ▼ -2202.7% |
| 2020 | -0.22x | $-6.80 Million | $-6.80 Million | $31.15 Million | ▲ +42.9% |
| 2019 | -0.38x | $-3.57 Million | $-3.59 Million | $9.34 Million | — |